{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:17:16Z","timestamp":1794374236461,"version":"4.9.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2022-KH131278"],"award-info":[{"award-number":["RS-2022-KH131278"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00355464"],"award-info":[{"award-number":["RS-2024-00355464"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60684-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:12:43Z","timestamp":1751368363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effective treatment of systemic candidiasis by synergistic targeting of cell wall synthesis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7062-7494","authenticated-orcid":false,"given":"Ju Yeon","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Kyoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6461-957X","authenticated-orcid":false,"given":"Eunhee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5209-2164","authenticated-orcid":false,"given":"Ayoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Weissleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-3185","authenticated-orcid":false,"given":"Yong Pil","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-902X","authenticated-orcid":false,"given":"Hyun Jung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"60684_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41579-024-01062-w","volume":"22","author":"GD Brown","year":"2024","unstructured":"Brown, G. D. et al. The pathobiology of human fungal infections. Nat. Rev. Microbiol. 22, 687\u2013704 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"60684_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.15698\/mic2020.06.718","volume":"7","author":"K Kainz","year":"2020","unstructured":"Kainz, K., Bauer, M. A., Madeo, F. & Carmona-Gutierrez, D. Fungal infections in humans: the silent crisis. Microb. Cell 7, 143\u2013145 (2020).","journal-title":"Microb. Cell"},{"key":"60684_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature10947","volume":"484","author":"MC Fisher","year":"2012","unstructured":"Fisher, M. C. et al. Emerging fungal threats to animal, plant and ecosystem health. Nature 484, 186\u2013194 (2012).","journal-title":"Nature"},{"key":"60684_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","volume":"9","author":"GC de Oliveira Santos","year":"2018","unstructured":"de Oliveira Santos, G. C. et al. Candida infections and therapeutic strategies: Mechanisms of action for traditional and alternative agents. Front. Microbiol. 9, 1351 (2018).","journal-title":"Front. Microbiol."},{"key":"60684_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Florl","year":"2024","unstructured":"Lass-Florl, C. et al. Invasive candidiasis. Nat. Rev. Dis. Primers 10, 20 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"60684_CR6","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.tcsw.2021.100063","volume":"7","author":"S Ahmadipour","year":"2021","unstructured":"Ahmadipour, S., Field, R. A. & Miller, G. J. Prospects for anti-Candida therapy through targeting the cell wall: A mini-review. Cell Surf. 7, 100063 (2021).","journal-title":"Cell Surf."},{"key":"60684_CR7","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","volume":"121","author":"Y Lee","year":"2021","unstructured":"Lee, Y., Puumala, E., Robbins, N. & Cowen, L. E. Antifungal drug resistance: Molecular mechanisms in Candida albicans and Beyond. Chem. Rev. 121, 3390\u20133411 (2021).","journal-title":"Chem. Rev."},{"key":"60684_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher, M. C. et al. Tackling the emerging threat of antifungal resistance to human health. Nat. Rev. Microbiol. 20, 557\u2013571 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"60684_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","volume":"21","author":"SR Lockhart","year":"2023","unstructured":"Lockhart, S. R., Chowdhary, A. & Gold, J. A. W. The rapid emergence of antifungal-resistant human-pathogenic fungi. Nat. Rev. Microbiol. 21, 818\u2013832 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"60684_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","volume":"18","author":"J Berman","year":"2020","unstructured":"Berman, J. & Krysan, D. J. Drug resistance and tolerance in fungi. Nat. Rev. Microbiol. 18, 319\u2013331 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"60684_CR11","doi-asserted-by":"publisher","first-page":"332001","DOI":"10.1088\/1361-6528\/ad4bed","volume":"35","author":"A Izadi","year":"2024","unstructured":"Izadi, A., Paknia, F., Roostaee, M., Mousavi, S. A. A. & Barani, M. Advancements in nanoparticle-based therapies for multidrug-resistant candidiasis infections: a comprehensive review. Nanotechnology 35, 332001 (2024).","journal-title":"Nanotechnology"},{"key":"60684_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature16963","volume":"530","author":"JL Nishikawa","year":"2016","unstructured":"Nishikawa, J. L. et al. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction. Nature 530, 485\u2013489 (2016).","journal-title":"Nature"},{"key":"60684_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nri3897","volume":"15","author":"MG Netea","year":"2015","unstructured":"Netea, M. G., Joosten, L. A., van der Meer, J. W., Kullberg, B. J. & van de Veerdonk, F. L. Immune defence against Candida fungal infections. Nat. Rev. Immunol. 15, 630\u2013642 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"60684_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202206437","volume":"34","author":"J He","year":"2022","unstructured":"He, J., Ye, Y., Zhang, D., Yao, K. & Zhou, M. Visualized gallium\/lyticase-integrated antifungal strategy for fungal keratitis treatment. Adv. Mater. 34, e2206437 (2022).","journal-title":"Adv. Mater."},{"key":"60684_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300320","volume":"36","author":"MJ Oh","year":"2024","unstructured":"Oh, M. J. et al. Nanozyme-based robotics approach for targeting fungal infection. Adv. Mater. 36, e2300320 (2024).","journal-title":"Adv. Mater."},{"key":"60684_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404107","volume":"36","author":"C Lochenie","year":"2024","unstructured":"Lochenie, C. et al. Photosensitizer-amplified antimicrobial materials for broad-spectrum ablation of resistant pathogens in Ocular infections. Adv. Mater. 36, e2404107 (2024).","journal-title":"Adv. Mater."},{"key":"60684_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673\u2013694 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"60684_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.tips.2024.02.007","volume":"45","author":"V Kumar","year":"2024","unstructured":"Kumar, V., Huang, J., Dong, Y. & Hao, G. F. Targeting Fks1 proteins for novel antifungal drug discovery. Trends Pharmacol. Sci. 45, 366\u2013384 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"60684_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202313791","volume":"36","author":"A Vaidya","year":"2024","unstructured":"Vaidya, A. et al. Expanding RNAi to Kidneys, Lungs, and Spleen via selective ORgan Targeting (SORT) siRNA lipid nanoparticles. Adv. Mater. 36, e2313791 (2024).","journal-title":"Adv. Mater."},{"key":"60684_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/mt.2010.136","volume":"18","author":"Y Chen","year":"2010","unstructured":"Chen, Y., Zhu, X., Zhang, X., Liu, B. & Huang, L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 18, 1650\u20131656 (2010).","journal-title":"Mol. Ther."},{"key":"60684_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"60684_CR22","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Lipid Nanoparticles horizontal line From Liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"60684_CR23","doi-asserted-by":"publisher","first-page":"100166","DOI":"10.1016\/j.medidd.2023.100166","volume":"20","author":"N Angrish","year":"2023","unstructured":"Angrish, N. & Khare, G. Antisense oligonucleotide based therapeutics and its applications against bacterial infections. Med. Drug Discov. 20, 100166 (2023).","journal-title":"Med. Drug Discov."},{"key":"60684_CR24","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1073\/pnas.0337462100","volume":"100","author":"DD Matthew","year":"2003","unstructured":"Matthew, D. D., Constantine, G. H. & Douglas, H. T. Uptake and antifungal activity of oligonucleotides in Candida albicans. PNAS 100, 1530\u20131534 (2003).","journal-title":"PNAS"},{"key":"60684_CR25","doi-asserted-by":"publisher","first-page":"myac030","DOI":"10.1093\/mmy\/myac030","volume":"60","author":"D Araujo","year":"2022","unstructured":"Araujo, D. et al. Cationic lipid-based formulations for encapsulation and delivery of anti-EFG1 2\u2032 OMethylRNA oligomer. Med. Mycol. 60, myac030 (2022).","journal-title":"Med. Mycol."},{"key":"60684_CR26","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1021\/acsabm.1c00334","volume":"4","author":"D Araujo","year":"2021","unstructured":"Araujo, D. et al. Polyamide microsized particulate polyplex carriers for the 2\u2032-OMethylRNA EFG1 antisense oligonucleotide. ACS Appl. Bio. Mater. 4, 4607\u20134617 (2021).","journal-title":"ACS Appl. Bio. Mater."},{"key":"60684_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41586-023-05856-5","volume":"616","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Structural and mechanistic insights into fungal beta-1,3-glucan synthase FKS1. Nature 616, 190\u2013198 (2023).","journal-title":"Nature"},{"key":"60684_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41594-022-00791-x","volume":"29","author":"Z Ren","year":"2022","unstructured":"Ren, Z. et al. Structural basis for inhibition and regulation of a chitin synthase from Candida albicans. Nat. Struct. Mol. Biol. 29, 653\u2013664 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60684_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep26667","volume":"6","author":"Q Yu","year":"2016","unstructured":"Yu, Q. et al. Inhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells. Sci. Rep. 6, 26667 (2016).","journal-title":"Sci. Rep."},{"key":"60684_CR30","doi-asserted-by":"publisher","first-page":"110563","DOI":"10.1016\/j.materresbull.2019.110563","volume":"119","author":"N M","year":"2019","unstructured":"M, N. et al. Studies on the antifungal activity of biotemplated gold nanoparticles over Candida albicans. Mater. Res. Bull. 119, 110563 (2019).","journal-title":"Mater. Res. Bull."},{"key":"60684_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2217\/17435889.2.2.153","volume":"2","author":"JR McCarthy","year":"2007","unstructured":"McCarthy, J. R., Kelly, K. A., Sun, E. Y. & Weissleder, R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2, 153\u2013167 (2007).","journal-title":"Nanomedicine"},{"key":"60684_CR32","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1126\/science.1125559","volume":"312","author":"NL Rosi","year":"2006","unstructured":"Rosi, N. L. et al. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 5776 (2006).","journal-title":"Science"},{"key":"60684_CR33","doi-asserted-by":"publisher","first-page":"112167","DOI":"10.1016\/j.msec.2021.112167","volume":"126","author":"MJ Beha","year":"2021","unstructured":"Beha, M. J., Ryu, J. S., Kim, Y. S. & Chung, H. J. Delivery of antisense oligonucleotides using multi-layer coated gold nanoparticles to methicillin-resistant S. aureus for combinatorial treatment. Mater. Sci. Eng. C Mater. Biol. Appl. 126, 112167 (2021).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"60684_CR34","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7, 5577 (2012).","journal-title":"Int. J. Nanomed."},{"key":"60684_CR35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3109\/13693786.2010.486412","volume":"48","author":"C Alburquenque","year":"2010","unstructured":"Alburquenque, C. et al. Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp. Med. Mycol. 48, 1018\u20131023 (2010).","journal-title":"Med. Mycol."},{"key":"60684_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.carbpol.2018.04.091","volume":"195","author":"LGS Garcia","year":"2018","unstructured":"Garcia, L. G. S. et al. Effect of the molecular weight of chitosan on its antifungal activity against Candida spp. in planktonic cells and biofilm. Carbohydr. Polym. 195, 662\u2013669 (2018).","journal-title":"Carbohydr. Polym."},{"key":"60684_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203325","volume":"35","author":"S Lee","year":"2023","unstructured":"Lee, S., Hao, L. T., Park, J., Oh, D. X. & Hwang, D. S. Nanochitin and nanochitosan: Chitin nanostructure engineering with multiscale properties for biomedical and environmental applications. Adv. Mater. 35, e2203325 (2023).","journal-title":"Adv. Mater."},{"key":"60684_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijbiomac.2010.06.011","volume":"47","author":"AA Tayel","year":"2010","unstructured":"Tayel, A. A. et al. Anticandidal action of fungal chitosan against Candida albicans. Int. J. Biol. Macromol. 47, 454\u2013457 (2010).","journal-title":"Int. J. Biol. Macromol."},{"key":"60684_CR39","doi-asserted-by":"publisher","first-page":"527549","DOI":"10.1155\/2013\/527549","volume":"2013","author":"A Pena","year":"2013","unstructured":"Pena, A., Sanchez, N. S. & Calahorra, M. Effects of chitosan on Candida albicans: conditions for its antifungal activity. Biomed. Res. Int. 2013, 527549 (2013).","journal-title":"Biomed. Res. Int."},{"key":"60684_CR40","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1021\/acs.chemrev.0c01074","volume":"121","author":"CJ Whitfield","year":"2021","unstructured":"Whitfield, C. J. et al. Functional DNA-polymer conjugates. Chem. Rev. 121, 11030\u201311084 (2021).","journal-title":"Chem. Rev."},{"key":"60684_CR41","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3390\/polym14112293","volume":"14","author":"AH Hashem","year":"2022","unstructured":"Hashem, A. H., Shehabeldine, A. M., Ali, O. M. & Salem, S. S. Synthesis of chitosan-based gold nanoparticles: Antimicrobial and wound-healing activities. Polymers (Basel) 14, 2293 (2022).","journal-title":"Polymers (Basel)"},{"key":"60684_CR42","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fmicb.2019.00602","volume":"10","author":"PY Shih","year":"2019","unstructured":"Shih, P. Y., Liao, Y. T., Tseng, Y. K., Deng, F. S. & Lin, C. H. A potential antifungal effect of chitosan against Candida albicans is mediated via the inhibition of SAGA complex component expression and the subsequent alteration of cell surface integrity. Front. Microbiol. 10, 602 (2019).","journal-title":"Front. Microbiol."},{"key":"60684_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-018-2728-6","volume":"13","author":"P Foroozandeh","year":"2018","unstructured":"Foroozandeh, P. & Aziz, A. A. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res. Lett. 13, 339 (2018).","journal-title":"Nanoscale Res. Lett."},{"key":"60684_CR44","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46.14","author":"S Behzadi","year":"2017","unstructured":"Behzadi, S. et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46.14, 4218\u20134244 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"60684_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.34172\/apb.2021.078","volume":"11","author":"Z Salehi","year":"2021","unstructured":"Salehi, Z. et al. Susceptibility pattern of caspofungin-coated gold nanoparticles against clinically important Candida species. Adv. Pharm. Bull. 11, 693\u2013699 (2021).","journal-title":"Adv. Pharm. Bull."},{"key":"60684_CR46","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.3390\/molecules25215114","volume":"25","author":"WH Lo","year":"2020","unstructured":"Lo, W. H., Deng, F. S., Chang, C. J. & Lin, C. H. Synergistic antifungal activity of chitosan with fluconazole against Candida albicans, Candida tropicalis, and fluconazole-resistant strains. Molecules 25, 5114 (2020).","journal-title":"Molecules"},{"key":"60684_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1128\/AAC.01486-12","volume":"57","author":"LA Walker","year":"2013","unstructured":"Walker, L. A. & Gow, N. A. Munro, ted chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob. Agents Chemother. 57, 146\u2013154 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"60684_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biomedicines9040433","volume":"9","author":"M Gagliardi","year":"2021","unstructured":"Gagliardi, M. & Ashizawa, A. T. The challenges and strategies of antisense Oligonucleotide drug delivery. Biomedicines 9, 433 (2021).","journal-title":"Biomedicines"},{"key":"60684_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007892","volume":"15","author":"T Chen","year":"2019","unstructured":"Chen, T. et al. Exposure of Candida albicans beta (1,3)-glucan is promoted by activation of the Cek1 pathway. PLoS Genet. 15, e1007892 (2019).","journal-title":"PLoS Genet."},{"key":"60684_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y Lee","year":"2023","unstructured":"Lee, Y., Robbins, N. & Cowen, L. E. Molecular mechanisms governing antifungal drug resistance. NPJ Antimicrob. Resist. 1, 5 (2023).","journal-title":"NPJ Antimicrob. Resist."},{"key":"60684_CR51","doi-asserted-by":"publisher","first-page":"517529","DOI":"10.1155\/2012\/517529","volume":"2012","author":"A Brand","year":"2012","unstructured":"Brand, A. Hyphal growth in human fungal pathogens and its role in virulence. Int. J. Microbiol. 2012, 517529 (2012).","journal-title":"Int. J. Microbiol."},{"key":"60684_CR52","first-page":"100137","volume":"3","author":"GKK Reddy","year":"2022","unstructured":"Reddy, G. K. K., Padmavathi, A. R. & Nancharaiah, Y. V. Fungal infections: Pathogenesis, antifungals and alternate treatment approaches. Curr. Res. Microb. Sci. 3, 100137 (2022).","journal-title":"Curr. Res. Microb. Sci."},{"key":"60684_CR53","first-page":"10","volume":"5.3","author":"NA Gow","year":"2017","unstructured":"Gow, N. A., Latge, J. P. & Munro, C. A. The fungal cell wall: structure, biosynthesis, and function. Microbiol. Spectr. 5.3, 10\u20131128 (2017).","journal-title":"Microbiol. Spectr."},{"key":"60684_CR54","unstructured":"Smith, S. E. & Read, D. J. Mycorrhizal Symbiosis. (Academic Press, 2010)."},{"key":"60684_CR55","doi-asserted-by":"publisher","first-page":"34501","DOI":"10.1039\/D0RA04978F","volume":"10","author":"A Kilanowska","year":"2020","unstructured":"Kilanowska, A. & Studzinska, S. In vivo and in vitro studies of antisense oligonucleotides - a review. RSC Adv. 10, 34501\u201334516 (2020).","journal-title":"RSC Adv."},{"key":"60684_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/nar\/gkz1099","volume":"48","author":"J Duschmale","year":"2020","unstructured":"Duschmale, J. et al. In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3\u2032 and 5\u2032 thiophosphate linkages. Nucleic Acids Res. 48, 63\u201374 (2020).","journal-title":"Nucleic Acids Res."},{"key":"60684_CR57","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/0471142735.im1906s105","volume":"105","author":"HR Conti","year":"2014","unstructured":"Conti, H. R., Huppler, A. R., Whibley, N. & Gaffen, S. L. Animal models for candidiasis. Curr. Protoc. Immunol. 105, 1961 (2014).","journal-title":"Curr. Protoc. Immunol."},{"key":"60684_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-55","volume":"6","author":"AF Zuluaga","year":"2006","unstructured":"Zuluaga, A. F. et al. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55 (2006).","journal-title":"BMC Infect. Dis."},{"key":"60684_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102133","volume":"35","author":"E Backstrom","year":"2024","unstructured":"Backstrom, E. et al. Tissue pharmacokinetics of antisense oligonucleotides. Mol. Ther. Nucleic Acids 35, 102133 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"60684_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","volume":"87","author":"RS Geary","year":"2015","unstructured":"Geary, R. S., Norris, D., Yu, R. & Bennett, C. F. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv. Drug Deliv. Rev. 87, 46\u201351 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"60684_CR61","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bcpt.13555","volume":"128","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Prognostic value of liver and kidney function parameters and their correlation with the ratio of urine-to-plasma paraquat in patients with paraquat poisoning. Basic Clin. Pharmacol. Toxicol. 128, 822\u2013830 (2021).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"60684_CR62","doi-asserted-by":"publisher","first-page":"106587","DOI":"10.1016\/j.ijantimicag.2022.106587","volume":"59","author":"MI Balcerek","year":"2022","unstructured":"Balcerek, M. I., Stewart, A. G., Chapman, P. & Lazarus, S. Reducing the off-target endocrinologic adverse effects of azole antifungals\u2014can it be done? Int. J. Antimicrob. Agents 59, 106587 (2022).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"60684_CR63","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/jcpt.12417","volume":"41","author":"D Benjamin Lash","year":"2016","unstructured":"Benjamin Lash, D., Jolliff, J., Munoz, A. & Heidari, A. Cross-reactivity between voriconazole, fluconazole and itraconazole. J. Clin. Pharm. Ther. 41, 566\u2013567 (2016).","journal-title":"J. Clin. Pharm. Ther."},{"key":"60684_CR64","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/pharmaceutics13070989","volume":"13","author":"S Pereira","year":"2021","unstructured":"Pereira, S. et al. Lipoplexes to deliver Oligonucleotides in Gram-Positive and Gram-Negative bacteria: Towards treatment of blood infections. Pharmaceutics 13, 989 (2021).","journal-title":"Pharmaceutics"},{"key":"60684_CR65","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1021\/acs.molpharmaceut.3c00089","volume":"20","author":"N Duskunovic","year":"2023","unstructured":"Duskunovic, N., Im, S. H., Lee, J. & Chung, H. J. Effective mRNA delivery by condensation with cationic nanogels incorporated into liposomes. Mol. Pharm. 20, 3088\u20133099 (2023).","journal-title":"Mol. Pharm."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60684-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:07:37Z","timestamp":1751371657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60684"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60684-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5532"}}